Additional Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    Vanderbilt University Medical Center
    Nashville TN. 37232
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of California Los Angeles
    Los Angeles CA. 90095
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    Brigham and Womens Hospital
    Boston MA. 02115
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    New York University
    New York NY. 10016
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of Miami
    Miami FL. 33136
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of Washington
    Seattle WA. 98109
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of California at San Francisco
    San Francisco CA. 94143
    View Details

  • Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    St Louis MO. 63110
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Trois-Rivières QC. G9A 4P3
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Upland CA. 91786
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Montreal H3T 1E2
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    New York NY. 10029
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Gainesville FL. 32608
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Salt Lake City UT. 84108
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Houston TX. 77030
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Los Angeles CA. 92868
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Potsdam NY. 13676
    View Details